Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma
Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma
Active, not recruiting · NCT05737199 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma | ovarian squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-02-05 | NCT05737199 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| Niigata University Medical & Dental Hospital | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Niigata University Medical & Dental Hosptal | Niigata | Japan | 1 |